[SGMO] YoY Quarter Result on 31-Mar-2018 [#Q1]

Stock
[SGMO] Sangamo Therapeutics, Inc.
Announcement Date
09-May-2018
Financial Year
2018
Quarter
31-Mar-2018 [#Q1]
Profit Trend
QoQ- -54.21%
YoY- -21.37%
Quarter Report
SGMO's Result
SGMO's Financial Summary
View:
Show?
Quarter Result
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
Revenue 26,280 13,076 8,071 12,637 3,425 3,942 13,491 11.74%
PBT -45,677 -42,974 -42,203 -20,187 -16,632 -16,494 -6,067 39.95%
Tax 262 -61 -53 -588 0 -245 -748 -
NP -45,933 -42,913 -42,150 -20,187 -16,632 -16,494 -5,319 43.18%
Tax Rate - - - - - - - -
Total Cost 72,213 55,989 50,221 32,824 20,057 20,436 18,810 25.10%
Ratio Analysis
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
NP Margin -174.78 -328.18 -522.24 -159.75 -485.61 -418.42 -39.43 28.13%
Per Share
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
EPS -0.32 -0.37 -0.41 -0.23 -0.23 -0.23 -0.08 25.96%
EPS Diluted -0.32 -0.37 -0.41 -0.23 -0.23 -0.23 -0.08 25.96%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.